Literature DB >> 9401992

Sonographic, magnetic resonance imaging, and mammographic assessments of preoperative size of breast cancer.

W T Yang1, W W Lam, H Cheung, M Suen, W W King, C Metreweli.   

Abstract

High resolution sonographic (39 cases), magnetic resonance imaging (32 cases), and mammographic (35 cases) measurements of preoperative size of breast cancer were correlated with the pathologic size in 39 patients with breast carcinoma to determine the most accurate imaging technique for breast cancer size. There were nine T1, 21 T2, four T3, and four T4 tumors. Sonographic and magnetic resonance imaging measurements of tumor size demonstrated correlation coefficients of 0.92 and 0.93, respectively, both of which were superior to that of mammography (0.84). Sonographic tumor size evaluation thus is shown to be equivalent to magnetic resonance imaging in this study. Three of nine (33%), four of seven (57%), and four of eight (50%) T1 tumors would have been overstaged by ultrasonography, magnetic resonance imaging, and mammography, respectively. Three of 21 (14.3%), one of 16 (6.3%), and two of 18 (11.1%) T2 tumors would have been understaged by ultrasonography, magnetic resonance imaging, and mammography, respectively. We therefore found ultrasonography to be of value in the diagnosis and staging of breast cancer.

Entities:  

Mesh:

Year:  1997        PMID: 9401992     DOI: 10.7863/jum.1997.16.12.791

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  18 in total

1.  Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy.

Authors:  Anees B Chagpar; Lavinia P Middleton; Aysegul A Sahin; Peter Dempsey; Aman U Buzdar; Attiqa N Mirza; Fredrick C Ames; Gildy V Babiera; Barry W Feig; Kelly K Hunt; Henry M Kuerer; Funda Meric-Bernstam; Merrick I Ross; S Eva Singletary
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

2.  Accuracy of ultrasonography and mammography in predicting pathologic response after neoadjuvant chemotherapy for breast cancer.

Authors:  Jason D Keune; Donna B Jeffe; Mario Schootman; Abigail Hoffman; William E Gillanders; Rebecca L Aft
Journal:  Am J Surg       Date:  2010-04       Impact factor: 2.565

3.  Accuracy of tumour size assessment in the preoperative staging of breast cancer: comparison of digital mammography, tomosynthesis, ultrasound and MRI.

Authors:  Andrea Luparia; Giovanna Mariscotti; Manuela Durando; Stefano Ciatto; Davide Bosco; Pier Paolo Campanino; Isabella Castellano; Anna Sapino; Giovanni Gandini
Journal:  Radiol Med       Date:  2013-06-25       Impact factor: 3.469

4.  Non-surgical therapy and radiologic assessment of stage I breast cancer treatment with novel enzyme-targeting radiosensitization: Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, type II (KORTUC II).

Authors:  Jiro Hitomi; Kei Kubota; Yasuhiro Ogawa; Norihiko Hamada; Yoriko Murata; Akihito Nishioka
Journal:  Exp Ther Med       Date:  2010-07-20       Impact factor: 2.447

5.  Assessment of breast cancer tumour size using six different methods.

Authors:  Martina Meier-Meitinger; Lothar Häberle; Peter A Fasching; Mayada R Bani; Katharina Heusinger; David Wachter; Matthias W Beckmann; Michael Uder; Rüdiger Schulz-Wendtland; Boris Adamietz
Journal:  Eur Radiol       Date:  2010-12-30       Impact factor: 5.315

6.  Estimation of tumor size in breast cancer comparing clinical examination, mammography, ultrasound and MRI-correlation with the pathological analysis of the surgical specimen.

Authors:  Tomas Cortadellas; Paula Argacha; Juan Acosta; Jordi Rabasa; Ricardo Peiró; Margarita Gomez; Laura Rodellar; Sandra Gomez; Alejandra Navarro-Golobart; Sonia Sanchez-Mendez; Milagros Martinez-Medina; Mireia Botey; Carlos Muñoz-Ramos; Manel Xiberta
Journal:  Gland Surg       Date:  2017-08

7.  Comparison of mammography and ultrasound in detecting residual disease following bioptic lumpectomy in breast cancer patients.

Authors:  Xiufeng Wu; Qingzhong Lin; Jianping Lu; Gang Chen; Y I Zeng; Yinglan Lin; Ying Chen; Yaoqin Wang; Jun Yan
Journal:  Mol Clin Oncol       Date:  2016-01-14

Review 8.  The role of SPET and PET in monitoring tumour response to therapy.

Authors:  Chariklia Giannopoulou
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-06-14       Impact factor: 9.236

9.  Intraoperative micro-computed tomography (micro-CT): a novel method for determination of primary tumour dimensions in breast cancer specimens.

Authors:  Rong Tang; Mansi Saksena; Suzanne B Coopey; Leopoldo Fernandez; Julliette M Buckley; Lan Lei; Owen Aftreth; Frederick Koerner; James Michaelson; Elizabeth Rafferty; Elena Brachtel; Barbara L Smith
Journal:  Br J Radiol       Date:  2015-11-16       Impact factor: 3.039

10.  Automated breast volume scanner (ABVS) in assessing breast cancer size: A comparison with conventional ultrasound and magnetic resonance imaging.

Authors:  Rossano Girometti; Martina Zanotel; Viviana Londero; Anna Linda; Michele Lorenzon; Chiara Zuiani
Journal:  Eur Radiol       Date:  2017-10-10       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.